CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 498 enrolled / 498 target
Drug / intervention
Sculptra Aestheticdevice
Likely dose
Sculptra Aesthetic, at least 2 vials in each of at least 2 different treatment sessionsAI-extracted
Key inclusion· 2
  • Treated with Sculptra Aesthetic in non-facial areas at the study site
  • Available information about treatment dates and procedures
Key exclusion· 2
  • Active request by participant not to be involved in study or registry
  • Other conditions at investigator discretion that would exclude participation

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT05463978
NCT05463978N/ACompletedOn Track (10.5/mo)Completion was 44mo ago

A Multi-center Retrospective Chart Review to Evaluate the Safety of Sculptra Aesthetic When Used in Non-facial Areas

Galderma R&D·observational·Posted Jul 19, 2022·Updated Jun 12, 2026

In Brief

An observational study evaluating Sculptra Aesthetic for Non-facial Skin Aesthetic Conditions. Completed, enrolled 498 participants across 8 sites.

Detailed Summary

Multi-center retrospective chart review to evaluate the safety of Sculptra Aesthetic when used in non-facial areas

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
2023202420252026
First PostedJul 19, 2022
Enrollment StartJul 14, 2022
Primary CompletionOct 14, 2022
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 4.0 years ago

Arms & Interventions

Sculptra Aestheticother

Participants who had been treated with at least 2 vials in each of at least 2 different treatment sessions of Sculptra Aesthetic injections in non-facial areas.

Device: Sculptra Aesthetic

Interventions

Sculptra Aestheticdevice

Sculptra Aesthetic in non-facial areas